THYRA MALTESE: Open Payments
NPI 1861938490 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,322 in 60 payments from 15 companies in 2025. Trend: 2023 $2,355 · 2024 $5,560 · 2025 $1,322
Food & beverage: $1,322
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $376 |
| Janssen Biotech, Inc. | 12 | $242 |
| UCB, Inc. | 7 | $120 |
| E.R. Squibb & Sons, L.L.C. | 6 | $115 |
| Lilly USA, LLC | 6 | $113 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| GlaxoSmithKline, LLC. | 2 | $54 |
| Amgen Inc. | 2 | $42 |
| Sandoz Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
Products named: TREMFYA, RINVOQ, SKYRIZI, Bimzelx, ORENCIA, TALTZ, SAPHNELO, BENLYSTA.
Industry payments across SC — which companies pay providers there.
